• No results found

NCMM Molecular Medicine Research Course

N/A
N/A
Info
Nedlasting
Protected

Academic year: 2022

Share "NCMM Molecular Medicine Research Course"

Copied!
5
0
0

Laster.... (Se fulltekst nå)

Last ned nå ( 5 sider )

Fulltekst

(1)

NCMM Molecular Medicine Research Course

Course no.: MF9120BTS - Molecular Medicine (national PhD-level course) Time: November 8-19, 2021

Place: Oslo Science Park, Level 0, Hagen 1+2 (see daily plan)

Organized by: Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital

Topics and Programme

1. Disease mechanisms and development (8h)

a. Targeting signaling pathways in cancer (1h, Sigrid Skånland) b. Inflammation (2h, Guttorm Haraldsen/Espen Melum) c. Metabolic diseases, diabetes (2h, Pål Njølstad)

d. Epigenetics and chromatin structure (1h, Nikolina Sekulic) e. DNA repair mechanisms (1h, Hilde Nilsen)

f. Disease mechanism and risk factors of venous thrombosis (1h, Lynn Butler) 2. Animal models of disease (4h)

a. Stem cells (2h, Judith Staerk)

b. Disease mechanisms and animal models of cardiovascular disease (1h, Andreas Romaine)

c. The use of zebrafish to model and understand mechanisms underlying neurological disorder (1h, Camila Esguerra)

3. Biobanks, health registries and biomarker discovery (7 h)

a. Use of population biobanks to understand human disease (2h, Kristian Hveem) b. Predictive medicine: Use of health registries and epidemiology (2h, Trude E.

Robsahm)

c. Cancer biomarkers (1h, Helga Bergholtz)

d. Biomarkers for early diagnosis and management of heart diseases (2h, Torbjørn Omland)

4. Imaging disease (6h)

a. Introduction to imaging modalities (1h, Lars Tore Gyland Mikalsen) b. Translational Molecular Imaging in Cancer (1h, Emmet Mc Cormack) c. Imaging cardiovascular diseases in animal models and patients (2h, Bill

Louch/Magnus Arnonsen)

d. Brain MR imaging in schizophrenia and bipolar disorder (2h, Ole Andreassen)

5. Structure-based drug discovery (5h)

(2)

b. Basics of Chemical Biology and High throughput screening (1h, Johannes Landskron) c. Drug development in the pharmaceutical industry (1h, Herbert Nar, BI)

d. Molecular dynamics studies (1h, Matteo Dal Peraro, EPFL)

6. Tailored and personalized medicine (9h)

a. Introduction to Precision Medicine (1h, Janna Saarela)

b. Precision cancer medicine, implementation and the IMPRESS-Norway trial (1h, Kjetil Taskén)

c. Precision medicine in everyday practice - rare diseases (1h, Dag Undlien)

d. Drug sensitivity testing and personalized medicine (2h, Krister Wennerberg/ Bjørn Tore Gjertsen)

e. Utilizing common genetic variation to predict disease predisposition (2h, Samuli Ripatti, Elisabeth Widen)

f. Lipid vesicles and lipid nanoparticles for drug delivery and vaccination (1h, Irep Gözen)

7. Advanced cell-based therapies (5h)

a. Stem cells and their niche as a basis for future therapies (1h, Lorena Arranz) b. Cell based therapies in medicine – Laboratory work flow and clinical practice in

cancer treatment (2h, Else Marit Inderberg)

c. T cell receptor engineering and T cell therapies in cancer (1h, Johanna Olweus) d. Stem cell treatment in diabetes (1h, Hanne Scholz)

8. Computational biology (7h)

a. Computational Biology of Adaptive Immunity (1h, Victor Greiff) b. Single cell genomics (1h, Oliver Stegle)

c. Novel analytics in personalized medicine (2 h, Anthony Mathelier/Marieke Kuijjer) d. Deep learning in biomedicine (1h, Esa Pitkänen )

e. Germline vs somatic mutations: commonalties, distinctions, and interplay (1h, Sebastian Waszak)

f. Covid-19 and mathematical models (1h, Arnoldo Frigessi) 9. SARS-CoV-2 detection, vaccination and drug targeting (3 h)

a. SARS-CoV-2 – a study of replication and immunity (1h, Christine Hanssen Rinaldo, UiT)

b. Vaccine strategies (1h, Gunnveig Grødeland, KG Jebsen Center) 10. Organizational

a. Introduction and organization (1h, Elisa Bjørgo)

(3)

Week 1 Schedule; NCMM Molecular Medicine Research Course

Date Day/Room Time Topic Title Lecturer

08.11.2021 Mon

Hagen 1+2 09.00 –

09.15 Organizational Info & organization Elisa Bjørgo 08.11.2021 Mon

Hagen 3 09.15 –

11.00 Disease mechanisms - DNA repair mechanisms - Epigenetics and chromatin structure

- Hilde L. Nilsen - Nikolina Sekulic 08.11.2021 Mon

Hagen 1+2 11:15 –

13:00 TBD TBD TBD

08.11.2021 Mon

Hagen 1+2 14.00 –

15.45 Disease mechanisms - Targeting signaling pathways in cancer

- Disease mechanism and risk factors of venous thrombosis

- Sigrid Skånland - Lynn Butler 09.11.2021 Tue

Hagen 1+2 09.00 –

10.45 Disease mechanisms - Introduction to inflammation - Gut and liver inflammation

- Guttorm Haraldsen - Espen Melum 09.11.2021 Tue

Hagen 1+2 11.00 –

12.45 Animal models of

disease Stem cells Judith Staerk

09.11.2021 Tue

Hagen 1+2 14.00 –

15.45 - Animal models in

disease - The use of zebrafish to model and understand mechanisms underlying neurological disorder

- Disease mechanisms and animal models of

cardiovascular disease

- Camila Esguerra

- Andreas Romaine (zoom!)

10.11.2021 Wed

Hagen 1+2 09.00 –

10.45 Imaging disease - Introduction to imaging modalities

- Translational Molecular Imaging in Cancer

- Lars Tore Gyland Mikalsen

- Emmet Mc Cormack 10.11.2021 Wed

Hagen 1+2 11.00 –

12.45 Imaging disease Imaging cardiovascular diseases in animal models and patients

Bill Louch/ Magnus Aronsen

10.11.2021 Wed

Hagen 1+2 14.00 –

15.45 Imaging disease Brain MR imaging in schizophrenia and bipolar disorder

Ole Andreassen

11.11.2021 Thu

Hagen 1+2 09.00 –

10.45 Advanced cell-based

therapies Cell based therapies – Laboratory work flow and clinical practice

Else Marit Inderberg 11.11.2021 Thu

Hagen 1+2 11.00 –

12.45 - Advanced cell- based

therapies - T cell-based immunotherapy in cancer

- Stem cell treatment in diabetes

- Johanna Olweus - Hanne Scholz 11.11.2021 Thu

Hagen 1+2 14.00 –

15.45 - Advanced cell-based

therapies - Stem cells and their niche as a basis for future therapies - TBD

- Lorena Arranz

- TBD 12.11.2021 Fri

Hagen 1+2 09.00 –

10.45 Computational Biology -

Computational Biology of Adaptive Immunity

- Single cell genomics (zoom lecture)

- Victor Greiff - Oliver Stegle 12.11.2021 Fri

Hagen 1+2 11.00 –

12.45 Computational Biology Novel analytics in personalized

medicine Anthony

Mathelier/

Marieke Kuijjer 12.11.2021 Fri

Hagen 1+2 13.30 –

15.15 Computational Biology - Deep learning in biomedicine - Esa Pitkänen

(4)

- Germline vs somatic mutations: commonalties, distinctions, and interplay

- Sebastian Waszak

Week 2 Schedule; NCMM Molecular Medicine Research Course

Date Day/Room Time Topic Title Lecturer

15.11.2021 Mon

Hagen 1+2 09.00 – 10.45 Tailored and personalized medicine

- Introduction to Precision Medicine

- Precision cancer medicine, implementation and the IMPRESS-Norway trial

- Janna Saarela - Kjetil Taskén

15.11.2021 Mon

Hagen 1+2 11.00 – 12.45 Tailored and personalized medicine

- Precision medicine in everyday practice - rare diseases

- Lipid vesicles and lipid nanoparticles for drug delivery and vaccination

- Dag Undlien

- Irep Gözen

15.11.2021 Mon

Hagen 1+2 14.00 – 15.45 Tailored and personalized medicine

(zoom if necessary)

Drug sensitivity testing and personalized medicine in leukemia

Krister Wennerberg/

Bjørn Tore Gjertsen 16.11.2021 Tue

Hagen 1+2 09.00 – 10.45 Tailored and personalized medicine (online/zoom)

- Genomics in Disease Prevention and Management - Genomics in Action:

Preventing Ischemic Heart Disease

- Samuli Ripatti

- Elisabeth Widen

16.11.2021 Tue

Hagen 1+2 11.00 – 12.45 Biobanks, health registries and biomarker discovery

Predictive medicine: Use of health registries and epidemiology

Trude Eid Robsahm

16.11.2021 Tue

Hagen 1+2 14.00 – 15.45 Biobanks, health registries and biomarker discovery

Use of population biobanks to understand human disease

Kristian Hveem

17.11.2021 Wed

Hagen 1+2 09.00 – 10.45 Biobanks, health registries and biomarker discovery

Biomarkers for early diagnosis and management of heart diseases

Torbjørn Omland

17.11.2021 Wed

Hagen 1+2 11.00 – 12.45 - Biobanks, health registries and biomarker discovery

- Cancer biomarkers: from discovery to clinical practice

- TBD

-

Helga Bergholtz

- TBD 17.11.2021 Wed

Hagen 1+2 14.00 – 15.45 Disease

mechanisms Metabolic diseases,

diabetes Pål Njølstad

18.11.2021 Thu

Hagen 1+2 09.00 – 10.45 Structure-based

drug discovery - Introduction to structural biology and cryoEM in drug design

- Eva Cunha

18.11.2021 Thu

Hagen 1+2 11.00 – 12.45 Structure-based drug discovery (online/zoom)

- Molecular dynamics studies

- The Role of Structural Biology and Biophysics in Drug Discovery

- Matteo Dal Peraro - Herbert Nar

(5)

18.11.2021 Thu

Hagen 1+2 14.00 – 15.45 Structure-based

drug discovery - Basics of Chemical Biology and High throughput screening

- TBD

- Johannes Landskron - TBD 19.11.2021 Fri

Hagen 1+2 09.00 – 10.45 SARS-CoV-2 detection, vaccination and drug targeting

- SARS-CoV-2 – a study of replication and immunity

-

Vaccine strategies

- Christine H.

Rinaldo - Gunnveig Grødeland 19.11.2021 Fri

Hagen 1+2 11.15 – 12:00 - Computational

Biology - Covid-19 and

mathematical models - Arnoldo Frigessi 19.11.2021 Fri

Hagen 1+2 12.00 Organizational Summary course & Pizza Elisa Bjørgo

Referanser

Last ned nå ( PDF - 5 sider - 213.58 KB )

RELATERTE DOKUMENTER

Open call for Associate Investigators and Young Associate Investigators at Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo - Third Call

NCMM is also national contact partner in the EU-ESFRI project European Advanced Translational Infrastructure (www.EATRIS.eu) planning the future of translational research in

FRAMLEGGSNOTAT TIL FAKULTETSSTYRET

Føringer for NCMMs virksomhet er nedfelt i i) Partnerskapsavtale om Nordic EMBL Partnership in Molecular Medicine (inngått 5. Desember, 2008 og eventuelle senere fornyelser

Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease

1 Institute of Biotechnology, University of Helsinki, Helsinki, Finland; 2 Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway; 3 Center for Hematology

Visit the NoPSC web pages: www.ous-research.no/nopsc and Visit the NoPSC web pages: www.ous-research.no/nopsc and

The Experimental Hepatology Group and the Genomic and metagenomics group are organized at the Research Institute of Internal Medicine, Oslo University Hospital, while the

Common brain disorders are associated with heritable patterns of apparent aging of the brain

11 Institute of Clinical Medicine, University of Oslo, Oslo, Norway 36.. 12 Department of Radiology and Nuclear Medicine, Section of Neuroradiology, Oslo University Hospital,

Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53 949)

19 Medical Genetics Section, University of Edinburgh Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh,

Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults

61 NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital,

GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report form the COGENT consortium

Jebsen Centre for Psychosis Research, University of Bergen, Bergen, Norway; 10 Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway; 11 Department